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Abstract: Tetrodotoxin (TTX) is a low molecular weight (~319 Da) neurotoxin found in a 
number of animal species, including pufferfish. Protection from toxin tainted food stuffs 
requires rapid, sensitive, and specific diagnostic tests. An emerging technique for the 
detection of both proteins and nucleic acids is Fluidic Force Discrimination (FFD) assays. 
This simple and rapid method typically uses a sandwich immunoassay format labeled with 
micrometer-diameter beads and has the novel capability of removing nonspecifically 
attached beads under controlled, fluidic conditions. This technique allows for near real-
time, multiplexed analysis at levels of detection that exceed many of the conventional 
transduction methods (e.g., ELISAs). In addition, the large linear dynamic range afforded 
by FFD should decrease the need to perform multiple sample dilutions, a common 
challenge for food testing. By applying FFD assays to an inhibition immunoassay platform 
specific for TTX and transduction via low magnification microscopy, levels of detection of 
~15 ng/mL and linear dynamic ranges of 4 to 5 orders of magnitude were achieved. The 
results from these studies on the first small molecule FFD assay, along with the impact to 
detection of seafood toxins, will be discussed in this manuscript. 
Keywords:  tetrodotoxin; antibody inhibition assay; bioassay; Fluidic Force 
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1. Introduction  
Tetrodotoxin (TTX), a low molecular weight neurotoxin, is found in a number of organisms 
including pufferfish, California newts, parrotfish, frogs of the genus Atelopus, blue-ringed octopus, 
starfish, angelfish, and xanthid crabs [1,2]. This neurotoxin is believed to originate from certain 
bacteria including strains of Vibrio, Pseudomonas sp., and Alteromonas that are found associated with 
the host organism [3–5]. Tetrodotoxin toxicity is imparted by its high affinity to block voltage-gated 
sodium channels which transport Na
+ between the exterior and interior of cells [6]. Poisoning in 
humans is characterized by rapid onset of numbness in the face and extremities as well as mild 
gastrointestinal effects, with severe poisoning culminating in respiratory paralysis and death [7]. While 
tetrodotoxin poisoning is relatively rare in the United States [1], in Japan where pufferfish is 
considered a delicacy (i.e., fugu) there are reported to be 30–100 cases per year with a mortality  
of 6.4% [8]. 
In recent years, TTX has been found in the United States and international food stuffs. The most 
notable US cases include three chefs in California that became ill when they consumed pre-packaged 
fugu  [9] and two people in Illinois who ate pufferfish misbranded as monkfish [10]. From these 
incidents, it is clear that the most common organism that impacts public health and harbors TTX is 
pufferfish, which accumulate TTX in the gonads, liver, intestines, and skin [1]. Correct preparation of 
pufferfish and consumption of the muscle alone reduces the risk of poisoning; however, the techniques 
for preparation are difficult and prone to error. This potential contamination of the pufferfish muscle 
along with the inability to inhibit TTX action by proper cooking methods (e.g., freezing for storage, 
heating during cooking, using acid to cook) cause TTX to be a potentially dangerous foodborne 
pathogen. Furthermore, the LD50 for TTX in mammals is 2–10 μg/kg intravenously and 10–14 μg/kg 
subcutaneously [11]. The only country with an established regulatory limit for TTX is Japan [12]. 
While there is no established action level for TTX in the US, saxitoxin (action level of 80 μg STX 
equivalents per 100 g tissue) is considered to be comparable, given the similar toxicities and modes of 
action for the two toxins. 
The current standard for testing TTX in foodstuffs is the mouse bioassay [12,13]. This test, however 
accurate in determining toxicity of a sample, suffers from potential ethical concerns over the use of 
live animals. Furthermore, the mouse bioassay does not test for a specific toxin, just the time it takes 
for a mouse to die following intraperitoneal injection of a sample. In this assay, the time of death is 
proportional to toxicity; however, the dynamic range for this proportional relationship is small. Thus, 
many samples must be diluted and new mice injected to yield a result that falls within the quantitative 
dynamic range. In addition, a sample resulting in mouse incapacitation would need further 
confirmatory testing to determine the exact source toxin (e.g., TTX, STX, brevetoxin, etc.). Therefore 
a method that eliminates the use of live animals, tests for the specific presence of TTX, and provides a 
larger dynamic range would be beneficial. 
Functional methods relying on biological components (e.g., native receptors) have become popular 
alternatives in recent years. One such method relies on using sodium ion channels from rat brain 
membrane preparations and radio-labeled saxitoxin or tetrodotoxin (
3H-STX or 
3H-TTX) [14]. In this 
receptor binding assay (RBA), radio-labeled toxin and TTX compete for the receptors, with the signal 
then inversely proportional to sample toxicity [15,16]. Due to the nonspecific nature of receptor Mar. Drugs 2010, 8                             
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binding, this assay does not have the ability to distinguish between TTX and the STX congeners. In 
addition, the use of radioactive components makes the method expensive, limited by radiation safety 
regulations, and potentially hazardous to the user and environment. 
A common detection technique for foodborne toxins and small molecules is high performance 
liquid chromatography (HPLC) that is sometimes coupled with mass spectrometry (MS). These 
methods have been developed for TTX and allow for identification of the toxin and congeners that 
may be present [17–20]. Interestingly, recent studies have shown that both STX and TTX can be 
present in pufferfish, and thus using an LC/MS method can be advantageous in outbreak samples to 
identify the causative agent of illness [21]. However, HPLC and LC/MS can use harsh, 
environmentally deleterious solvents, and these techniques may not be suited to the rapid screening 
needed for the high number of potentially contaminated materials that would arise from a   
large outbreak. 
Alternative assays to the RBA have been shown to be successful as rapid screening tools. These 
assays mainly rely on antibodies that are specific to the desired toxin and therefore allow 
discrimination between TTX and other commonly occurring marine toxins. Many immunoassay 
formats and transduction techniques have been designed with perhaps the most common being the 
enzyme-linked immunosorbant assay (ELISA) [22–24]. Unfortunately, ELISA can be lengthy and 
require a lot of labor to complete. Recently developed immunoassays that focus on flow based 
systems, such as surface plasmon resonance biosensors [25], show promise for more rapidly detecting 
TTX and work to improve these technologies is underway. Other novel detection methods for TTX 
include surface-enhanced Raman spectroscopy with metallic nanoparticle arrays that are able to obtain 
the tetrodotoxin spectrum at concentrations as low as 0.9 ng/mL [26] and electrochemical 
immunosensors with ng/mL detection limits following 30 min assays [27]. 
An emerging assay option that uses a flow-based system and antibody recognition is Fluidic Force 
Discrimination (FFD). In FFD assays, a sample is mixed with secondary antibodies and conjugated 
microbead labels in solution. Next, the analyte-loaded beads are introduced to a microarray, captured 
at the corresponding primary antibody, and controlled fluidic forces are applied to preferentially 
remove nonspecifically bound beads. The beads remaining are counted to determine the analyte 
identity and concentration. Using this protocol, 35 aM staphylococcal enterotoxin B (SEB) was 
detected in <20 min [28] with a log-linear dose response curve covering six orders of magnitude. FFD 
assays have also been used to detect ricin and anthrax antigens, as well as several nucleic acid targets, 
including genomic DNA from Bacillus anthracis sterne, B. anthracis ames, and B. thuringiensis [29]. 
Additionally, a key advantage of FFD assays is that they are compatible with complex matrices and 
detection has been demonstrated in biological (e.g., blood, plasma, serum, saliva, urine, feces), 
environmental (e.g., waste water), and food (e.g., spinach, milk, apple juice) samples.  
In the work presented here, we extend FFD assays to the detection of small molecule targets. By 
combining a modified inhibition immunoassay with the FFD technology, a rapid and sensitive 
detection platform was developed. This proof of concept study not only indicated the ability of FFD to 
detect small molecules, specifically TTX in this case, it also showed that FFD can yield a large linear 
dynamic range of detection. This large dynamic range would decrease the number of times a sample 
would have to be diluted and run to quantitatively determine concentration thus saving time and Mar. Drugs 2010, 8                             
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expense. Herein, the substrate preparation, immunoassay format, detection technique, and the results 
obtained from preliminary studies will be discussed.  
2. Results and Discussion 
2.1. Immunoassay Platform and FFD Instrumentation  
FFD immunoassays have been developed with a focus on using sandwich immunoassays for rapid, 
sensitive, and selective antigen detection. In the most basic form of these assays, an antibody is 
immobilized on the flow cell surface, the antigen is then captured to the surface, and the bound 
complex is labeled with a secondary antibody. Antibody conjugated microbeads are then added to the 
flow cell that recognize the secondary antibody [28]. FFD is performed and the amount of beads bound 
to the surface quantified. However, for small molecules such as TTX, sandwich immunoassays are not 
amenable to detection, as it is rarely possible to bind two antibodies to these small analytes. To 
alleviate the size and antibody constraints, an immunoassay platform can be designed that takes 
advantage of single antibody binding in an inhibition immunoassay format. 
To design the substrate for FFD detection of TTX, modifications were made to a previously 
optimized biosensor platform (Figure 1a) [25]. A 1 part NH2-oligoethylene glycol (NH2-OEG) thiol is 
mixed with 9 parts OH-OEG thiol to create a substrate that is both bioresistant [30,31] and amenable to 
conjugation of TTX [23,32]. The immobilization reaction is performed by using the crosslinker 
formaldehyde to covalently attach TTX to the self-assembled monolayer (SAM). By immobilizing 
TTX on the surface in this manner, the CH2OH functionality and antibody-reactive portion of the 
molecule faces up and is available to bind anti-TTX. Based on this orientation then, an inhibition 
immunoassay can be performed where the mouse anti-TTX is captured and subsequently labeled by 
anti-mouse microbeads as shown in Figure 1b. Due to the nature of the inhibition immunoassay, the 
larger the concentration of TTX in the analyte solution, the less free antibodies there will be to bind to 
the substrate, and consequently the fewer microbeads observed upon readout. 
FFD assay instrumentation is shown in Figure 2. All assay steps occur in a microfluidic cell formed 
when the functionalized surface is mounted in a compression fit cartridge. This custom built platform 
mounts on an upright microscope and has five individually addressable sensing areas per substrate. 
Using a peristaltic pump in either push or pull mode, buffer and reagents can be added to and removed 
from the sensing areas. Following FFD, captured beads are imaged with low power microscopy (5×), 
and images are captured on a CCD camera. The bench top instrument shown here is a manual 
workhorse, well designed for assay development; however, in the future it should be feasible to 
develop an automated, shoe-box sized, portable instrument. Most of the components of this system 
have already been developed for the compact Bead Array Sensor System (cBASS
®), a field portable 
bioassay platform employing FFD assays and using magnetoresistive sensors to detect captured 
magnetic bead labels [33]. 
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Figure 1. (a) Tetrodotoxin surface immobilization via formaldehyde onto an NH2-OEG 
and OH-OEG mixed thiol monolayer, and (b) FFD inhibition immunoassay where the teal 
diamonds represent TTX.  
 
Figure 2. FFD instrument mounted on an upright microscope (System image). The 
functionalized substrate is held in the compression fit cartridge, and reagents are added and 
removed via the reagent wells in front of each of five individually addressable flow cells 
(Cartridge image). A peristaltic pump and six-way valve determine which flow cell is 
operational (Device image).  
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2.2. TTX Immunoassay Results 
After performing the inhibition immunoassay with TTX, the substrate is imaged through a   
5× microscope objective, and the image is captured with a CCD camera. To interrogate the quantity of 
microbeads that are immobilized on the surface, the image is processed using Image J software   
(Figure 3). The images on the far left represent raw data files where the top image has high coverage 
(antibody present), and the bottom image has low coverage (no antibody). The images are transformed 
with the software to yield a pure black and white representation of the surface. By using the software, 
the percent area covered by dark space is then determined, and this value is representative of 
microbead binding. From these data, it is seen that at full coverage, the substrate had approximately 
73% of the surface covered by microbeads. At the other extreme, when there was no antibody (Ab) 
present in the assay, the substrate exhibited about 12% coverage. This allows a range of 61% for the 
immunoassay calibration curve. To determine the linear dynamic range and assay sensitivity, the assay 
is then performed by mixing various concentrations of TTX with the antibody in the immunoassay 
format shown in Figure 1b, and the data processing is performed as described herein. 
Figure 3. Far left: Images of surface after FFD performed for positive control (Ab, top 
image) and negative control (no Ab, bottom image). Images are then transformed using 
Image J software. 
 
Convert to % 
area covered
Transform 
image to black 
and white
Convert to % 
area covered
Transform 
image to black 
and white
72.9% Æ Ab
11.6% Æ no Ab
Convert to % 
area covered
Transform 
image to black 
and white
Convert to % 
area covered
Transform 
image to black 
and white
72.9% Æ Ab
11.6% Æ no Ab
 
 
Upon completion of these immunoassays and normalization of the data, the results can be shown in 
a calibration curve (Figure 4). As expected, when TTX concentration is low there are many antibodies 
available to bind to the surface, resulting in a larger number of beads and thus a high signal. The 
inverse is true in which a high TTX concentration consumes the antibodies in solution, and therefore 
no signal is seen. The curve, ranging from 1 to 100,000 ng/mL TTX, shows a linear trend when the 
normalized signal is plotted with respect to the log of TTX concentration. This large dynamic range 
may offer advantages over other techniques as fewer sample dilutions would be necessary to determine 
an unknown concentration. Furthermore, the sensitivity of the assay, as defined by the IC20 (inhibitory Mar. Drugs 2010, 8                             
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concentration of 20% at 0.8 normalized signal), is 14 ng/mL which compares well to HPLC and 
LC/MS methods. 
Figure 4. Standard curve for TTX immunoassay with the normalized response versus TTX 
concentration used in the immunoassay. The number of replicate measurements for each 
concentration (N) is 2 (0.1, 100,000 ng/mL), 4 (1000 ng/mL), 5 (10,000 ng/mL), and 6 (1, 
10, 100 ng/mL). Curve has 4 to 5 orders of linear dynamic range (between 1 and   
100,000 ng/mL) with a fit of R
2 = 0.969, y = -0.1732 log(x) + 0.9523. Variation in N is due 
to substrate availability and the desire to perform more replicates near the limit of 
detection and in the linear dynamic range. 
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One drawback seen in the current data arises from the high standard deviations of each 
concentration. These relative errors, on the order of 10–15%, could lead to a less quantitative assay. 
We attribute these errors to nonspecific adsorption of the microparticles to the gold surface, as 
previous FFD experiments using non-gold surfaces yielded much lower standard deviations [28,33]. 
The gold surface, however, is not essential for FFD performance and was only utilized because of the 
well-established surface chemistry for TTX on gold platforms [25]. Current research is focused on 
redesigning the substrate conjugation chemistry to eliminate the gold platform and decrease the error 
while maintaining the specificity, sensitivity and large dynamic range of this assay. 
Further experiments indicated an advantage to the TTX immunoassay not previously incorporated 
into FFD assays. In surface plasmon resonance biosensors, assay platforms can be reconditioned by 
removing the antibody from the substrate at the end of each experiment [34] which can minimize error, 
reduce cost per sample, and decrease analysis time. This potential regeneration of substrates was 
investigated by immersing the used surfaces in a 50 mM NaOH solution and placing on a shaker for 1 
hr. After rinsing the slides with water and drying with N2(g), it is expected that the microbeads and anti-
TTX will be removed from the surface leaving a substrate with just TTX immobilized to the SAM. 
Upon regeneration and running further immunoassays on an individual slide, only minor changes in 
nonspecific binding (5%) and signals (7.5%) that appeared uniform throughout additional regeneration 
cycles were observed. This process then also appears to add a source of error in that regeneration was Mar. Drugs 2010, 8                             
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not complete. As such, regeneration was found to be feasible but the optimal conditions, such as using 
acidic regeneration solutions to avoid potential base sensitivity of TTX, are being investigated as an 
area of improvement for this immunoassay.  
3. Experimental Section  
3.1. Materials  
Anti-TTX monoclonal antibody (1 mg lyophilized protein) was purchased from Hawaii Biotech, 
Inc. (Aiea, HI), and TTX was procured from Sankyo Co, Ltd (Tokyo, Japan). Monobasic potassium 
phosphate (100mM), dibasic potassium phosphate (100 mM), 37% formaldehyde solution, 
triethylamine, and glacial acetic acid were obtained from Sigma-Aldrich (St. Louis, MO).   
HS-(CH2)11-EG4-OH and HS-(CH2)11-EG6-NH2 hydrochloride were synthesized by ProChimia 
Surfaces (Sopot, Poland). Ethanol (absolute, anhydrous, ACS/USP grade) was purchased from 
Pharmaco AAPER (Shelbyville, KY). 50% w/w sodium hydroxide solution was procured from J.T. 
Baker (Phillipsburg, NJ). Sheep anti-mouse, 2.8 μm Dynabeads were purchased from Invitrogen 
(Carlsbad, CA). Gold substrates (146 Å titanium adhesion layer, 3000 Å gold on glass microscope 
slides) were prepared using the AJA Sputtering Unit at the University of Maryland Nanocenter 
(College Park, MD). All water used in these experiments was 18.2 MΩ·cm (Millipore MilliQ 
Academic, Billerica, MA). 
3.2. Substrate Preparation  
A mixed SAM of oligoethylene glycol (OEG) alkanethiol (hydroxyl-terminated and amine-
terminated forms) on gold is prepared by modifying a procedure to form TTX surfaces for surface 
plasmon resonance biosensors [25]. This monolayer allows for covalent linking of tetrodotoxin to the 
surface (NH2-OEG) via formaldehyde coupling [23,32] as well as minimization of nonspecific protein 
adsorption (OH-OEG) [30,31]. Gold slides are ozone cleaned (20 min, NovaScan PSD-UV, Ames, 
IA), rinsed with water and then ethanol, and dried with N2(g). The dry slides are immersed into the 
mixtures (described next) for 18 hours. Briefly, 5 mM ethanolic solutions of each thiol are prepared. 
To generate the SAM with a 1:9 mixture of NH2-OEG thiol to OH-OEG thiol, 46.5 mL ethanol,  
1.5 mL triethylamine, 0.2 mL NH2-OEG thiol, and 1.8 mL OH-OEG thiol are mixed together. The 
triethylamine addition to the SAM formation allows for a smoother surface with less   
unbound thiols [35].  
After monolayer formation, the slide is removed from solution, rinsed with ethanol, 10% acetic acid 
in ethanol, followed by ethanol and dried with N2(g). This substrate is then reacted with a mixture of 
932.6  μL 100 mM pH 7.0 phosphate buffer, 41.8 μL of 10 mg/mL TTX, and 69.6 μL 37% 
formaldehyde. The formaldehyde functions as a one-carbon crosslinker which is able to covalently 
bind the TTX to the thiolate surface. Furthermore, this conjugation does not tie up the antibody 
binding motif located on the CH2OH side of TTX [25]. The reaction proceeds for 72 hrs at 37 °C, and 
after formation, the substrates may be stored at 4 °C until use. Upon removal, the chip is rinsed with 
DI water and dried with N2(g). Mar. Drugs 2010, 8                             
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3.3. FFD Setup  
FFD assays were performed with a custom built instrument mounted on an upright microscope. The 
TTX-functionalized substrate is housed in a compression-sealed fluid cartridge with five individually 
addressable flow cells [36]. At the front of each flow cell is a 200 μL well used for introduction and 
exchange of reagents. The opposing side of the cartridge is connected to a buffer reservoir and 
peristaltic pump. FFD substrate conditioning begins by pumping buffer through the cartridge to the 
base of the reagent well. 
3.4. Inhibition Immunoassay  
As TTX is a small molecule that is challenging to detect directly, an inhibition immunoassay was 
employed. One part TTX sample in buffer (1× PBS, 5% Carnation dried skim milk) is mixed with  
9 parts 1.1 μg/mL anti-TTX in buffer for 10 min. This inhibition assay mixture is then pulled into the 
FFD cartridge until the flow cell is filled, and the mixture is exposed to the TTX-functionalized 
surface for 5 min. During this time, antibodies not occupied with TTX antigen from the sample can 
bind to the TTX molecules on the substrate. Next, the mixture is pumped out of the cartridge and 
removed from the reagent well which simultaneously refills the flow cell with buffer. Then, the 2.8 μm 
diameter beads conjugated with sheep anti-mouse antibodies are pulled into the flow cell and allowed 
to settle for 3 min. This allows the beads to bind to any surface-bound TTX monoclonal antibodies. 
Finally, buffer is pumped through the flow cell at a controlled speed to remove nonspecifically 
attached beads, as previously described in detail [28,33]. For each substrate, which had five sample 
flow cells, one cell is used as a positive control (no TTX, Ab), one cell as a blank (no TTX, no Ab), 
and three cells as immunoassay samples (TTX and Ab). 
3.5. Data Processing 
Beads remaining after the FFD assay are imaged with low power (5×) optical microscopy, and 
images are captured with a CCD camera. Using Image J software (http://rsbweb.nih.gov/ij/index.html), 
the images are flattened, thresholded, and digitized to distinguish beads and background. A fixed area 
(100 × 100 pixels) is selected, and the percent area of beads determined. For each channel, an average 
of five images was taken, and the coverage of beads determined. The images are then compared to 
both a blank signal (i.e., no TTX and no Ab) and a no inhibition, positive control signal (i.e., no TTX 
but Ab in solution) on the same assay substrate. For uniformity between chips, the average sample 
signal had the nonspecific adsorption, as indicated in the blank run average signal, subtracted. Next, 
this result was divided by the positive control average signal that is due to just antibody binding. This 
process yields a normalized signal response. These normalized values for a single concentration with 
multiple sample runs (as indicated by N) are averaged together and plotted versus original 
concentration of TTX in the sample prior to antibody dilution. 
4. Conclusions 
This work has demonstrated the first competitive FFD immunoassay. The FFD immunoassay has 
the potential to detect TTX in complex matrices by using a sensitive, selective assay surface and Mar. Drugs 2010, 8                             
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controlled fluidic detachment of nonspecifically bound microparticles. In these studies, a substrate 
with covalently linked TTX was used as a platform for inhibition immunoassays that allowed for 4-5 
orders of linear magnitude and detection limits of approximately 15 ng/mL. This rapid, sensitive 
platform could decrease sample preparation and run times thus allowing for a superior screening assay 
to current methods. Research is underway to improve the current immunoassay by decreasing the 
standard deviation in replicates through better surface formation and regeneration.  
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